OPKO Health, Inc. (OPK) income statement
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.69+0.07 (+4.32%)
Close on Nov 18, 2026Market cap $1.26BP/E –Yield –
OPKO Health, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 40.8%
- Operating margin
- -8.2%
- Net margin
- -12.4%
- Return on equity, FY2025
- -17.1%
Financial strength
- Current ratio
- 3.35
- Debt to equity
- 0.00
- Debt to assets
- 0.1%
- Cash to current liabilities
- 201.4%
Valuation
- P/E ratio
- –
- Price to sales
- 2.15
- Price to book
- 1.07
- Dividend yield
- –
See a number that looks wrong?